Abstract-v-I. A radiometric micro-volume procedure for measurement of erythrocytic hexose monophosphate shunt (HMS) activity in intact cells in vitro is described.
INTRODUCTION
In persons genetically deficient in erythrocytic lucose-6-phosphate dehydrogenase (G6PD), a hemolytic anemia is generally believed to result from .the inability of the deficient erythrocyte to generate reduction potential in response to oxidative chalnge presented by certain drugs (Carson and rischer, 1966; Beutler, 1978; Gordon-Smith, 1980) ; ()wever, the mechanism by which oxidation may be ated to hemolysis is unknown (Keller, 1971; Carnet al., 1981) . In this regard, the HMS is a likely bject of investigation because HMS-generated DPH is required for reduction of glutathione, and uced glutathione affords the primary protection ainst oxidative challenge in the erythrocyte (Keller, ;71; Srivastava et aI., 1980) . The determination of f\,1S activity levels has recently been used by Kirkn et al. (1980) for the investigation of possible des of metabolic regulation operating on the nt, and by Carson et al. (1981) to differentiate at t two mechanisms through which HMS stimun is achieved. he methods used in these and similar inigations (Rose and O'Connell, 1963; Welt et al., ; Gaetani et al., 1974; Harvey and Kaneko, 1977) odified versions of the procedure described by and Yonemoto (1958) . In these procedures, I of drug-erythrocyte-glucose isotope mixture ubated in a sealed vessel containing a hydroxide from which HMS-liberated 14COZ is quantitated. procedure we have developed also uses real of HMS-generated 14COZ but has been deto whom inquiries and reprint requests should be ressed. ews of the authors do not reflect the opinions of the artment of the Army or the Department of Defense.
signed to allow simultaneous measurement of several treatment groups with a high number of replicates.
This design is illustrated in Fig. I . The final incubation volume is 50 pi and the 14COZ trap seals the microtiter well which serves as the incubation vessel. This report presents the results obtained using the micro-volume technique. The procedure appears to be somewhat inefficient in recovery of HMS-liberated 14COZ, but it offers replicable, quantitative data which may be statistically analyzed with a high degree of confidence.
MATERIALS AND METHODS

Buffers
A physiological balanced salts solution (PBSS) buffer was prepared by addition of the following chemicals (Sigma Fig. I . Schematic representation of hexose monophosphate shunt (HMS) activity measurement by the micro-volume procedure. The incubation mixture is 50 III and the Ba(OH)2 soaked CO 2 trap is 20 mrrr', The Ba14COJ product precipitates in the filter pad and its emission is quantitated by gas flow spectrometry. 
Reagents
Reagent grade sodium nitrite (Aldrich Chemical Co., Inc., Milwaukee, Wisconsin, U.S.A.) stock solution (250 mM) was prepared in PBSS. Solutions for tests were prepared by dilution of the stock in PBSS. Nitrite solutions older than I hr were not used.
Saturated barium hydroxide was prepared by addition of 250 g reagent grade anhydrous barium hydroxide (Fisher Scientific Co., Fair Lawn, New Jersey, U.S.A.) to approx. 300 ml autoclaved distilled and deionized water, cooled under vacuum. This mixture was gently shaken under vacuum for 10min and then held under vacuum overnight before use. The saturated stock Ba(OHh solution was maintained under vacuum to minimize exposure to atmospheric CO 2,
Erythrocytes
Ten ml whole blood were withdrawn by venipuncture from a 24-year-old Caucasian male (with no family history of hemolytic sensitivity), added to 40 ml PBS (25°C) and centrifuged immediately at 4°C, 500 g for 10 min. The buffy coat was removed by aspiration prior to decanting the supernatant. The red cell pellet was resuspended in 40 ml PBSS (4°C) and again centrifuged as before. This centrifugal wash was repeated once more and the pellet plus PBSS was adjusted to a total volume of 10m!. Without disturbing the red cell pellet, 500 mg human serum albumin (essentially globulin free, Fraction V, Sigma Chemical Co.) was allowed to dissolve into the supernatant. The preparation was mixed gently and kept at O°C until used. Red cell preparations older than two hours were not used. Albumin was added to the incubation mixture as a component to aid in solubilization of hydrophobic HMS-stimulating agents used in related experiments.
Incubation
Twenty-five /ll of 14C-glucose solution were added to each well of a microtiter tray (Unipec Inc., Rockville, Maryland, U.S.A.). Sodium nitrite solution (12.5 /ll) was added to these wells immediately before addition of red blood cells. For measurement of nonstimulated HMS activity, PBSS was substituted for the nitrite solution. A dropper bottle of saturated Ba(OH)2 solution and filter pads (circular 20 mnr', Scheicher and Schull Inc., Keene, New Hampshire' U.S.A.) were prepared prior to addition of erythrocytes, to ensure rapid sealing of microtiter wells and to minimize air-exposure of the stock bottle of hydroxide reagent.
Red cell suspension (12.5 (d, O°C) was added to each well of a replicate set of ten wells. One drop of Ba(OH)2 was quickly added to each filter pad for the set and the soaked pads were immediately placed over the wells. Trays were sealed with friction-fit lids, shaken gently for about 10sec and placed at 37°C under ambient atmosphere for 30 min.
HMS activity measure
Following incubation, filter pads were placed on aluminum planchettes (20 mm") held in plastic sample storage trays and rapidly dried under infrared light. The emission rate from Ba 14CO) on each pad was determined using an argon-methane (9: I) gas flow, «, {3 proportional spectrometer (LB 5110, Tennelec Inc., Oak Ridge, Tennessee, U.S.A.). The following equation was used for HMS activity calculation:
1.0/lCi 1.0/lmol glucose dpm x
x ------,-_i__ 2.22 X 10 6 dpm n {I Ci 1000 nmol CO 2 1 x x x --pmol glucose 0.0125 ml RBC 0.5 hr = nmol CO 2 trapped' ml RBC-1.hr-1
Because 1 mol 14C02 is released per mol 14C-glucose oxidized, it is valid to express HMS activity in terms of glucose oxidized on the basis of recovered 14C0 2 quantitation, but only if close to 100% recovery of 14C02 has been demonstrated. As described herein, the micro-volume procedure does not permit complete recovery of 14C02; incubation was not terminated by addition of acid which would drive CO 2 from solution. It was found that the micro-volume procedure was 32% efficient in recovery of 14C02 when acid treatment was omitted. While it is possible to include acid treatment in this procedure, doing so was found to decrease the rapidity of the procedure. We elected to omit acid treatment and to express HMS activity in terms of 14COZ trapped rather than glucose oxidized.
The n /l Ci term in the equation depends on the specific activity of the isotope and its treatment with non-labeled substrate. In the experiments reported, n = 0.
(D[1-14C]glucose) or 0.55 (D[2-14C]glucose).
Statistical analysis
Tests of significance of differences between two means were conducted using the analysis of variance (ANOV A) F-test as described by Sokal and Rohlf (1981) . Tests of significance of differences among more than two means were conducted using the Student-Newman-Keuls (SNK) test. All ANOV A tests were carried out using a 95% degree of certainty and the statistical tables employed were those compiled by Rohlf and Sokal (1981) .
RESULTS
Stimulation of HMS activity from 0 to 80 mM NaNG 2 is shown in Fig. 2 where two activities are plotted. These plots represent activity measured from (I) D[I-14C]glucose incubation, and (2) D[2-14C]glucose incubation. Activity measurement using the 1_ 14 C glucose isotope accounts for glucose molecules having made a single pass through the HMS and the 2_ 14C glucose isotope provides a measure of glucose carbon recycling through the HMS (Brin and Yonemoto, 1958) . The sum of the two activity means was considered to represent total HMS activity. Total HMS acttvity was significantly greater (P < 0.001) than activity measured from 1_ ' 4C glucose incubation alone at sodium nitrite concentrations greater than 5.0 mM. Below this concentration the two activities were insignificantly
At maximum HMS activity (20 mM NaNO z ), glucose recycling accounted for 16% of total HMS activity. Saturation of activity was observed between 10 and 20 mM NaNO z , as evidenced by an insignificant (P > 0.10) difference between the means. The 37% decrease in HMS activity between 20 and 80 mM NaN0 2 was significant (P < 0.001).
At the lowest nitrite concentration (0.625 mM), HMS activity was significantly greater (P < 0.001) than control activity. Each activity increase between 0, 0.625, and 2.5mM NaN0 2 was significant (P < 0.001).
This experiment was repeated on a separate occasion and HMS activities at several nitrite concentrations were compared by SNK and found to be uniformly similar (P > 0.05). In both experiments mean coefficients of variation were calculated for each treatment group and found to range between 2 and 8%.
Statistical analysis of the means used to construct the HMS stimulation plot illustrated in Fig. 2 has provided a profile of red cell response to sodium nitrite-induced oxidative challenge. The following conclusions were drawn from these measurements:
(I) HMS activation induced by nitrite was sigmoid, i.e. acceleration of HMS activity was bimodal; between 0 and 2.5 mM NaN0 2 the increase was linear at a rate of 4.2 x 10-3 mol CO z' mol NaN0 2 -I .111.-1 . Between 2.5 and 5.0 mM NaN0 2 the increase was linear at a rate of 11.7 x 10-3 mol CO 2'mole NaN0 2 -I. hr-'. (2) Nitrite treatment saturated HMS activity between 10 and 20 mM NaNO z with an activity maximum of 57 units (nmol COz trapped' ml RBC-I . hr-'). HMS activities at 10 and 20 mM NaN0 2 were not significantly different.
(3) HMS activity means at concentrations greater than 20 mM NaN0 2 were significantly diminished by as much as 37%.
(4) Nitrite-induced glucose carbon recycling through the HMS made a significant contribution to total HMS activity at nitrite concentrations greater than 2.5 mM NaNO z . Below 5.0 mM NaN0 2 recycling activity was not detectable.
Nitrite-induced glucose carbon recycling accounted for~16% of total HMS activity. Though this contribution was significant (P < 0.001), it did not alter the shape of the HMS response curve. Activation was sigmoidal, saturated between 10 and 20 mM NaNO z , and was diminished between 20 and 80 mM NaN0 2 whether or not correction for recycling was made.
DISCUSSION
The micro-volume procedure is a method in which a reproducible, highly resolved profile of oxidantinduced elevation of HMS activity can be obtained. The method also offers the advantages of requiring relatively minute quantities of blood and HMS stimulant samples.
The units of HMS activity employed herein are not directly comparable with unit values reported elsewhere (usually as Ilmol glucose oxidizedrnl RBC-" hr :"). However, comparison of relative HMS activities reveals published values in good agreement with those obtained using the microvolume procedure. For example, Methylene Blueinduced elevation of HMS activity has been reported as 51-fold (Gaetani et aI., 1974) , 48-fold (Metz et al., 1977) , and 52-fold (Kirkman et al., 1980) , whereas the micro-volume procedure measured a 45-fold elevation of HMS above baseline activity (Baird, 1984) . Further agreement is evident among estimates of the Methylene Blue-induced glucose carbon recycling contribution to total HMS activity; 34% (Brin and Yonemoto, 1958), 27% (Harvey and Kaneko, 1977) , 39% (Kirkman et al., 1980) , and 28% using the micro-volume procedure (data not given). These comparisons indicate that the indirect measure of HMS activity provided by this procedure is reliable.
The micro-volume procedure provides reproducible estimates of HMS activity with rapidity, allowing simultaneous measurement of a large number of experimental treatments with replication sufficient for statistical analysis of the data with a high degree of confidence. In this laboratory the micro-volume procedure has been employed to examine the relationship between HMS activation and the recently described proteolytic system in erythrocytes which is activated by oxidative stress (Goldberg and Boches, 1982) . It has been found that sodium nitriteinduced proteolysis is sensitive to the level of HMS activity, whereas Methylene Blue may stimulate the HMS independently of proteolytic activity (Baird, 1984) . These observations may be related to the fact that nitrite-induced activation of the HMS was distinctly sigmoidal (Fig. 2) and that induced by Methylene Blue was strongly hyperbolic (Kirkman et al., 1980; Baird, 1984) . The micro-volume procedure is well-suited to detecting such differences in HMS response.
This procedure also offers the advantage of requiring relatively minute quantities of blood and test oxidant. We have studied the oxidative activity of various putative primaquine metabolites in human erythrocytes in vitro (Baird et al., 1983) . These compounds are very limited in supply; reproducible estimates of their effects on the HMS were obtained at several concentrations with an expenditure of < 5 mg per compound.
SUMMARY
A procedure which permits simultaneous measurement of HMS activity in intact erythrocytes in vitro from 200 individual incubation mixtures in a single experiment is described. The incubation mixture (washed RBC, oxidant, 14C-glucose; I: I :2) is 50 pI contained in a micro titer well sealed with a Ba(OHksoaked paper filter pad which traps evolved 14C0 2 with 32% efficiency. The emission rate from Ba l4C0 3 precipitate is measured directly from the filter pad by a gas flow, a, fJ detector. The procedure has been used to define a highly resolved, reproducible profile of elevation of HMS activity with increasing NaN0 2 concentration. The data given illustrate the information-gathering potential this method offers. The large number of replicates possible allow one to detect relatively small departures from normal HMS activity; e.g. elevation of erythrocytic HMS activity in vivo by the hemolytic antimalarial, primaquine, has been estimated to be ::s;0.20-fold above baseline (Welt et al., 1971) . The procedure may also be particularly useful when one is experimentally limited by the amounts of blood and/or test compound available.
